REVOLUTIONIZING SPERM SELECTION FOR ENHANCED FERTILITY CONTROL

LICENSING & PARTNERING OPPURTUNITIES


The landscape of sperm selection for in vitro fertilization (IVF) is marked by challenges, where conventional methods struggle to identify sperm with optimal competency for fertilization and embryo development. In response, the ZP2 Peptide Beads emerge as a distinctive solution. These beads, incorporating the N-terminal region of ZP2, offer a unique platform for sperm selection. The ZP2 Peptide Beads present specific advantages: a targeted approach to successful sperm binding and penetration, translational studies showcasing superior sperm competency, an abundant source of reagents for selection, and a cost-effective, seamlessly integrated protocol within the IVF lab workflow. This innovation represents a significant step forward in the realm of sperm selection, addressing existing limitations and providing a more nuanced approach to fertility control and assisted reproductive technologies (ART).

The Advantages

  • Biological Relevance: The ZP2 peptide beads emulate the natural process of binding and penetration through the zona pellucida, crucial for fertilization in mice and humans.
  • Selective Competency: Unlike traditional sperm selection methods, this approach identifies and selects a subpopulation of human sperm with superior competency for fertilization and embryo development.
  • Reversibility and Superior Viability: The initial reversible binding of sperm to the ZP2 peptide beads opens avenues for short-term selection, preserving sperm motility and competency..

Inventors

Matteo Avella

Sidra Medicine